Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Roberto Collado‐Borrell
Observed names:
Collado-Borrell Roberto,
Collado-Borrell, Roberto,
R Collado-Borrell,
R. Collado‐Borrell,
Roberto Collado-Borrell
Institutions:
Hospital General Universitario Gregorio Marañón,
Instituto de Investigación Sanitaria Gregorio Marañón
Observed institutions:
Hospital General Universitario Gregorio Marañón,
Instituto de Investigación Sanitaria Gregorio Marañón
ORCID:
0000-0001-7639-0082
Observed ORCID:
0000-0001-7639-0082
OpenAlex ID:
A5036747390
Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis
2020
·
Roberto Collado-Borrell
, Vicente Escudero-Vilaplana
, et al.
·
Journal of Medical Internet Research
·
99
PDF
Smartphone applications for cancer patients; what we know about them?
2016
·
Roberto Collado-Borrell
, Vicente Escudero-Vilaplana
, et al.
·
PubMed
·
69
Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis
2020
·
Miguel Ángel Amor-García
, Roberto Collado-Borrell
, et al.
·
JMIR mhealth and uhealth
·
51
PDF
Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account
2016
·
Roberto Collado-Borrell
, Vicente Escudero-Vilaplana
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
48
Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey
2018
·
Roberto Collado-Borrell
, Vicente Escudero-Vilaplana
, et al.
·
Journal of Medical Internet Research
·
42
ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling
2025
·
Marina Gomez-Llobell
, Carlos Serra Smith
, et al.
·
Bone Marrow Transplantation
·
38
PDF
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale
2021
·
Álvaro Narrillos-Moraza
, Patricia Gómez-Martínez-Sagrera
, et al.
·
JMIR mhealth and uhealth
·
33
PDF
Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective
2021
·
María Belen Marzal-Alfaro
, Vicente Escudero-Vilaplana
, et al.
·
Frontiers in Oncology
·
30
PDF
Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study
2020
·
Roberto Collado-Borrell
, Vicente Escudero-Vilaplana
, et al.
·
JMIR mhealth and uhealth
·
24
PDF
Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app
2019
·
Roberto Collado-Borrell
, Vicente Escudero-Vilaplana
, et al.
·
Journal of Oncology Pharmacy Practice
·
18
Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes.
2022
·
Roberto Collado-Borrell
, Vicente Escudero-Vilaplana
, et al.
·
PubMed
·
16
Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting
2020
·
Vicente Escudero-Vilaplana
, Antonio Calles
, et al.
·
Frontiers in Oncology
·
16
PDF
Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice
2020
·
Vicente Escudero-Vilaplana
, Roberto Collado-Borrell
, et al.
·
Expert Opinion on Drug Safety
·
16
Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice
2021
·
Juan Vicente-Valor
, Vicente Escudero-Vilaplana
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
·
14
Validation of a Questionnaire to Assess the Usability of and User Experience with Mobile Health Applications
2024
·
Anna de Dios López
, Jordi Real
, et al.
·
Healthcare
·
13
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
2022
·
Vicente Escudero-Vilaplana
, Roberto Collado-Borrell
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
13
Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer
2022
·
Vicente Escudero-Vilaplana
, Elsa Bernal
, et al.
·
Frontiers in Oncology
·
11
Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities
2018
·
Julieta González
, Matías Quiroga
, et al.
·
Expert Opinion on Drug Safety
·
11
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain
2021
·
Esther Chamorro-de-Vega
, Carmen-Guadalupe Rodriguez-Gonzalez
, et al.
·
Expert Review of Clinical Pharmacology
·
10
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease
2020
·
Alejandra Melgarejo-Ortuño
, Vicente Escudero-Vilaplana
, et al.
·
Journal of Oncology Pharmacy Practice
·
9
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
2023
·
Javier De Castro
, Amelia Insa
, et al.
·
BMC Pulmonary Medicine
·
8
PDF
A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital
2022
·
Cristina Villanueva-Bueno
, Roberto Collado-Borrell
, et al.
·
Frontiers in Public Health
·
8
PDF
Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study
2021
·
Ana Rosa Rubio-Salvador
, Vicente Escudero-Vilaplana
, et al.
·
International Journal of Environmental Research and Public Health
·
8
Aggressiveness of end-of-life cancer care: what happens in clinical practice?
2020
·
Estela García-Martín
, Vicente Escudero-Vilaplana
, et al.
·
Supportive Care in Cancer
·
8
Medication guide for the perioperative management of oral antineoplastic agents in cancer patients
2021
·
Cristina Villanueva-Bueno
, Vicente Escudero-Vilaplana
, et al.
·
Expert Opinion on Drug Safety
·
7
Show more works
View as search
Works count:
68
Citation count:
766
H-index:
15
I10-index:
21
Year
Topic
Type